Overview
Lobbying Costs
75,000€
Financial year: Jan 2015 - Dec 2015
Lobbyists (Full time equivalent)
0.5 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Baxter Healthcare SA (Baxter)
EU Transparency Register
84050217165-45 First registered on 16 Nov 2011
Goals / Remit
Description:
Baxter manufactures and markets products that save and sustain the lives of people with kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices and pharmaceuticals to create products that advance patient care worldwide.
Baxter has spun-off its biotech franchise as of July 1st 2015, named Baxalta.
One of Baxter's competitive strengths is its diverse technological expertise and commitment to scientific innovation. The company's unique combination of capabilities in medical devices and pharmaceuticals sets it apart from other companies in the healthcare industry.
Goals:
• Baxter interacts with the EU Institutions on the legislation which has an impact on the healthcare industry through its participation in debates and public consultations
• Ensure equal access to treatment and innovative medicines to patients
• Apply innovative science to develop specialty therapeutics and medical products that save and sustain patients’ lives
• Improve conditions for prevention, treatment and care to address unmet needs
• Raise awareness and support the voice of patients suffering from chronic and life threatening diseases
• Support policy development aiming at improving regulatory processes for the healthcare sector and the competitiveness of research and industryMain EU files targeted
EU initiatives, policies and legislative files related to the field of healthcare policy and patient access
Address
Head Office
Thurgauerstrasse, 130
Glattpark
Zurich 8152
SWITZERLANDEU Office
boulevard d'Angleterre 2-4
Braine l'Alleud 1420
BELGIUM -
People
Total lobbyists declared
2
Employment time Lobbyists 25% 2 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 08 Mar 2016
Name Start date End Date Ms Ioana Enache 29 Jan 2020 29 Jan 2021 Mr Frederik ULRICHS 31 Aug 2017 20 Apr 2018 Mr Frederik ULRICHS 15 Mar 2016 12 Mar 2017 Ms Maria RODRIGUEZ SANCHEZ 12 Mar 2015 20 Oct 2015 Mr Toon DIGNEFFE 06 Mar 2015 22 Oct 2015 Mr Frederik ULRICHS 05 Mar 2015 03 Mar 2016 Ms Maria RODRIGUEZ SANCHEZ 11 Feb 2014 11 Feb 2015 Ms Astrid Jankowitsch 29 Nov 2014 22 Oct 2015 Mr Frederik ULRICHS 25 Feb 2014 03 Mar 2015 Mr Toon DIGNEFFE 11 Feb 2014 11 Feb 2015 Mrs Maria RODRIGUEZ SANCHEZ 11 Feb 2014 27 Jan 2015 Mr Frederik ULRICHS 19 Mar 2013 25 Feb 2014 Mr Toon DIGNEFFE 12 Mar 2013 12 Feb 2014 Mrs Maria RODRIGUEZ SANCHEZ 12 Mar 2013 12 Feb 2014 Toon DIGNEFFE 29 Feb 2012 08 Feb 2013 Frederik ULRICHS 27 Feb 2012 08 Feb 2013 Mrs Maria RODRIGUEZ SANCHEZ 08 Feb 2012 08 Feb 2013 Complementary Information
None declared
Person in charge of EU relations
Mr Sandra Gaisch-Hiller (Senior Director Government Affairs)
Person with legal responsibility
Mr Pierre Destexhe (Associate General Counsel)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Eucomed, Amcham EU
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2015 - Dec 2015
Lobbying costs for closed financial year
75,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
Legislative initiatives and policy issues in the field of healthcare policy and patient access
Other activities
Legislative initiatives and policy issues in the field of healthcare policy and patient access.
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 26 Feb 2015 Location Brussels Subject Blood directive Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
- Meetings